Tag Archives: Par Pharmaceutical

May, 2015

  • 19 May

    Endo to Acquire Par Pharmaceutical for $8 Billion

    In an effort to boost its generics business, Endo International PLC has agreed to buy Par Pharmaceutical Holdings Inc. for more than $8 billion. The company said that it has entered into a definitive agreement under which it will acquire privately-held Par from TPG in a transaction valued at $8.05 …